{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:53:14Z","timestamp":1778053994618,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.canlet.2014.07.023","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T11:08:08Z","timestamp":1406286488000},"page":"160-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy"],"prefix":"10.1016","volume":"353","author":[{"given":"Ivana","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Majem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinta","family":"Pallar\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"del R\u00edo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"P\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Baiget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00ed","family":"Barnadas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2014.07.023_bib0010","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2014.07.023_bib0015","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJMra0802714","article-title":"Lung cancer","volume":"359","author":"Herbst","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.canlet.2014.07.023_bib0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/JTO.0b013e3181c6f035","article-title":"First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review","volume":"5","author":"Goffin","year":"2010","journal-title":"J. Thorac. Oncol"},{"key":"10.1016\/j.canlet.2014.07.023_bib0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2014.07.023_bib0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","article-title":"Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy","volume":"24","author":"Reed","year":"1998","journal-title":"Cancer Treat. Rev"},{"key":"10.1016\/j.canlet.2014.07.023_bib0035","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum resistance: the role of DNA repair pathways","volume":"14","author":"Martin","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.canlet.2014.07.023_bib0040","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.biocel.2007.05.006","article-title":"Nuclear excision repair-based personalized therapy for non-small cell lung cancer: from hypothesis to reality","volume":"39","author":"Simon","year":"2007","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1016\/j.canlet.2014.07.023_bib0045","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2217\/pgs.12.91","article-title":"Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?","volume":"13","author":"Giovannetti","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.canlet.2014.07.023_bib0050","doi-asserted-by":"crossref","first-page":"e38150","DOI":"10.1371\/journal.pone.0038150","article-title":"Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients","volume":"7","author":"Yin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2014.07.023_bib0055","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1517\/17425250902973711","article-title":"Pharmacogenomics of platinum-based chemotherapy in NSCLC","volume":"5","author":"Hildebrandt","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol"},{"key":"10.1016\/j.canlet.2014.07.023_bib0060","first-page":"493","article-title":"Platinum drugs and DNA repair mechanisms in lung cancer","volume":"34","author":"Bonanno","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canlet.2014.07.023_bib0065","series-title":"AJCC Cancer Staging Manual","year":"2010"},{"key":"10.1016\/j.canlet.2014.07.023_bib0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2014.07.023_bib0075","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Cancer Institute (NCI), Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Published: May 28, 2009 (v4.03: June 14, 2010)."},{"key":"10.1016\/j.canlet.2014.07.023_bib0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"10.1016\/j.canlet.2014.07.023_bib0085","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gr.137323.112","article-title":"Annotation of functional variation in personal genomes using RegulomeDB","volume":"22","author":"Boyle","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.canlet.2014.07.023_bib0090","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"AC-19","author":"Akaike","year":"1974","journal-title":"IEEE Trans. Autom. Control"},{"key":"10.1016\/j.canlet.2014.07.023_bib0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/JTO.0b013e3181ffe909","article-title":"Pharmacogenetic and germline prognostic markers of lung cancer","volume":"6","author":"Horgan","year":"2011","journal-title":"J. Thorac. Oncol"},{"key":"10.1016\/j.canlet.2014.07.023_bib0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12032-010-9443-1","article-title":"Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis","volume":"28","author":"Wei","year":"2011","journal-title":"Med. Oncol"},{"key":"10.1016\/j.canlet.2014.07.023_bib0105","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1097\/JTO.0b013e3182307e1f","article-title":"Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin\/gemcitabine-treated advanced non-small cell lung cancer patients","volume":"6","author":"Ludovini","year":"2011","journal-title":"J. Thorac. Oncol"},{"key":"10.1016\/j.canlet.2014.07.023_bib0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.lungcan.2011.05.023","article-title":"Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy","volume":"75","author":"Ren","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2014.07.023_bib0115","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/cncr.26562","article-title":"Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study","volume":"118","author":"Joerger","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2014.07.023_bib0120","first-page":"555","article-title":"Comparison of two human ovarian carcinoma cell lines (A2780\/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene","volume":"16","author":"Yu","year":"2000","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.canlet.2014.07.023_bib0125","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","article-title":"XPD polymorphisms: effects on DNA repair proficiency","volume":"21","author":"Lunn","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2014.07.023_bib0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.seminoncol.2003.12.011","article-title":"Molecular predictors of response to chemotherapy in lung cancer","volume":"31","author":"Rosell","year":"2004","journal-title":"Semin. Oncol"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351400370X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351400370X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T06:23:17Z","timestamp":1538374997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438351400370X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S030438351400370X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2014.07.023","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2014.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}